ArticleGlobal heart2026
Hypertension Control in Bangladesh: Changes, Sociodemographic Variation, and Socioeconomic Inequality from the 2017-18 to 2022 Bangladesh Demographic and Health Surveys.
Article in Global heart, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Hypertension is a major public health challenge in Bangladesh, yet population-level blood pressure control remains poorly characterized. This study estimated changes in population-level hypertension control between the Bangladesh Demographic and Health Survey (BDHS) 2017-18 and BDHS 2022 and examined sociodemographic variation and socioeconomic inequality in hypertension control. Methods: Nationally representative BDHS 2017-18 ( Findings: Among individuals with hypertension, control increased from 12.5% (95% CI: 11.3-13.8) in 2017-18 to 19.3% (17.5-21.2) in 2022, alongside increases in awareness from 42.4% (40.5-44.4) to 54.3% (51.9-56.6) and treatment from 37.0% (35.2-38.9) to 44.6% (42.1-47.0). Hypertension prevalence was 27.5% (26.5-28.5) in 2017-18 and 20.5% (19.6-21.4) in 2022. Adjusted control improved across most sociodemographic groups, with the largest increases among older adults (+6.5%), females (+6.3%), urban residents (+6.8%), individuals with higher education (+7.3%), and residents of Sylhet (+7.9%) and Chattogram (+7.2%) divisions. Socioeconomic inequality also increased between 2017-18 and 2022, with a persistent pro-rich pattern (CnI: 0.11 to 0.13; SII: 8.5% to 15.1%; RII: 1.99 to 2.22). Conclusion: Population-level hypertension control in Bangladesh improved between survey rounds, although socioeconomic and geographic disparities persisted. Differences in survey implementation and measurement methods warrant cautious interpretation of changes over time. Strengthening equitable primary care and medication access may help sustain improvements and reduce disparities.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.